154 related articles for article (PubMed ID: 29802692)
1. Association of Two CD44 Polymorphisms with Clinical Outcomes of Gastric Cancer Patients.
Bitaraf SM; Mahmoudian RA; Abbaszadegan M; Mohseni Meybodi A; Taghehchian N; Mansouri A; Forghanifard MM; Memar B; Gholamin M
Asian Pac J Cancer Prev; 2018 May; 19(5):1313-1318. PubMed ID: 29802692
[TBL] [Abstract][Full Text] [Related]
2. Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma.
Winder T; Ning Y; Yang D; Zhang W; Power DG; Bohanes P; Gerger A; Wilson PM; Lurje G; Tang LH; Shah M; Lenz HJ
Int J Cancer; 2011 Sep; 129(5):1096-104. PubMed ID: 21105049
[TBL] [Abstract][Full Text] [Related]
3. CD44 single nucleotide polymorphism and isoform switching may predict gastric cancer recurrence.
Suenaga M; Yamada S; Fuchs BC; Fujii T; Kanda M; Tanaka C; Kobayashi D; Fujiwara M; Tanabe KK; Kodera Y
J Surg Oncol; 2015 Nov; 112(6):622-8. PubMed ID: 26416034
[TBL] [Abstract][Full Text] [Related]
4. Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients.
Stotz M; Herzog SA; Pichler M; Smolle M; Riedl J; Rossmann C; Bezan A; Stöger H; Renner W; Berghold A; Gerger A
Anticancer Res; 2017 Apr; 37(4):2011-2018. PubMed ID: 28373475
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Cyclin D1 and CD44 Expression in Gastric Adenocarcinoma.
Ibrahim HM; AbdElbary AM; Mohamed SY; Elwan A; Abdelhamid MI; Ibrahim A
J Gastrointest Cancer; 2019 Sep; 50(3):370-379. PubMed ID: 29497929
[TBL] [Abstract][Full Text] [Related]
6. CD44 Genotypes Are Associated with Susceptibility and Tumor Characteristics in Colorectal Cancer Patients.
Márquez-González RM; Saucedo-Sariñana AM; Barros-Núñez P; Gallegos-Arreola MP; Pineda-Razo TD; Marin-Contreras ME; Flores-Martínez SE; Sánchez-Corona J; Rosales-Reynoso MA
Tohoku J Exp Med; 2020 Feb; 250(2):109-119. PubMed ID: 32115493
[TBL] [Abstract][Full Text] [Related]
7. Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.
Yue Z; Song Y; Wang Z; Luo Y; Jiang L; Xing L; Xu H; Zhang X
J Surg Oncol; 2010 Jul; 102(1):68-72. PubMed ID: 20578081
[TBL] [Abstract][Full Text] [Related]
8. Expression of Cancer Stem Cell Marker CD44 and Its Polymorphisms in Patients with Chronic Gastritis, Precancerous Gastric Lesion, and Gastric Cancer: A Cross-Sectional Multicenter Study in Thailand.
Tongtawee T; Wattanawongdon W; Simawaranon T; Kaewpitoon S; Kaengpenkae S; Jintabanditwong N; Tangjanyatham P; Ratchapol W; Kangwantas K; Dechsukhum C; Leeanansaksiri W; Kaewpitoon N; Matrakool L; Panpimanmas S
Biomed Res Int; 2017; 2017():4384823. PubMed ID: 29445738
[TBL] [Abstract][Full Text] [Related]
9. An individual coding polymorphism and the haplotype of the SPARC gene predict gastric cancer recurrence.
Winder T; Wilson PM; Yang D; Zhang W; Ning Y; Power DG; Bohanes P; Gerger A; Tang LH; Shah M; Lenz HJ
Pharmacogenomics J; 2013 Aug; 13(4):342-8. PubMed ID: 22491017
[TBL] [Abstract][Full Text] [Related]
10. Expression of microRNA-328 Functions as a Biomarker for Recurrence of Early Gastric Cancer (EGC) After Endoscopic Submucosal Dissection (ESD) by Modulating CD44.
Xue HG; Yang AH; Sun XG; Lu YY; Tian ZB
Med Sci Monit; 2016 Dec; 22():4779-4785. PubMed ID: 27923017
[TBL] [Abstract][Full Text] [Related]
11. CD44/CD24 expression in recurrent gastric cancer: a retrospective analysis.
Yong CS; Ou Yang CM; Chou YH; Liao CS; Lee CW; Lee CC
BMC Gastroenterol; 2012 Jul; 12():95. PubMed ID: 22839505
[TBL] [Abstract][Full Text] [Related]
12. CD44 Predicts Early Recurrence in Pancreatic Cancer Patients Undergoing Radical Surgery.
Hsu CP; Lee LY; Hsu JT; Hsu YP; Wu YT; Wang SY; Yeh CN; Chen TC; Hwang TL
In Vivo; 2018; 32(6):1533-1540. PubMed ID: 30348713
[TBL] [Abstract][Full Text] [Related]
13. Gene Combination of CD44 rs187116, CD133 rs2240688, NF-κB1 rs28362491 and GSTM1 Deletion as a Potential Biomarker in Risk Prediction of Breast Cancer in Lower Northern Thailand.
Sapcharoen K; Sanguansermsri P; Yasothornsrikul S; Muisuk K; Srikummool M
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2493-2502. PubMed ID: 31450925
[TBL] [Abstract][Full Text] [Related]
14. Predictive Value of CD44 in Muscle-Invasive Bladder Cancer and Its Relationship with IL-6 Signaling.
Wu CT; Lin WY; Chen WC; Chen MF
Ann Surg Oncol; 2018 Nov; 25(12):3518-3526. PubMed ID: 30128900
[TBL] [Abstract][Full Text] [Related]
15. Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms--a case-control study in an Omani population.
Al-Moundhri MS; Al-Nabhani M; Burney IA; Al-Farsi AA; Al-Bahrani B
Mol Carcinog; 2009 Dec; 48(12):1170-6. PubMed ID: 19676106
[TBL] [Abstract][Full Text] [Related]
16. Single Nucleotide Polymorphism of the Enhancer of Zeste Homolog 2 Gene rs2072408 is Associated with Lymph Node Metastasis and Depth of Primary Tumor Invasion in Gastric Cancer.
Sun B; Lin Y; Wang X; Lan F; Yu Y; Huang Q
Clin Lab; 2016 Nov; 62(11):2099-2105. PubMed ID: 28164661
[TBL] [Abstract][Full Text] [Related]
17. Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients.
Qiu Y; Hu Y; Zhang ZY; Ye L; Xu FH; Schneider ME; Ma XL; Du YX; Zuo XB; Zhou FS; Chen G; Xie XS; Zhang Y; Xia HZ; Wu JF; Du WD
J Cancer Res Clin Oncol; 2014 Dec; 140(12):2143-56. PubMed ID: 25009318
[TBL] [Abstract][Full Text] [Related]
18. CD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.
Chou YE; Hsieh MJ; Chiou HL; Lee HL; Yang SF; Chen TY
Biomed Res Int; 2014; 2014():231474. PubMed ID: 24971320
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of DNA Methyltransferase 3b and Association with Development and Prognosis in Gastric Cancer.
Wang C; Jia Z; Cao D; You L; Jin M; Wu X; Wen S; Cao X; Jiang J
PLoS One; 2015; 10(8):e0134059. PubMed ID: 26262893
[TBL] [Abstract][Full Text] [Related]
20. Examination of cancer cells exposed to gastric serosa by serosal stamp cytology plus RT-PCR is useful for the identification of gastric cancer patients at high risk of peritoneal recurrence.
Miki Y; Yashiro M; Ando K; Okuno T; Kitayama K; Masuda G; Tamura T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Osawa M; Hirakawa K; Ohira M
Surg Oncol; 2017 Dec; 26(4):352-358. PubMed ID: 29113652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]